What is the recommendation for primary prevention in patients on moderate-dose statins?
The Work Group decided upon a Strong recommendation for Recommendation 6 and a Weak recommendation for Recommendation 7. For primary prevention in patients on moderate-dose statins, we suggest against maximizing the statin dose due to the lack of evidence proving added cardiovascular benefits and the risks of higher dose statins. (Weak against | Reviewed, New-replaced)